Provided by Tiger Fintech (Singapore) Pte. Ltd.

ATYR PHARMA INC

5.30
-0.0300-0.56%
Post-market: 5.440.1400+2.64%19:17 EDT
Volume:2.47M
Turnover:13.14M
Market Cap:471.72M
PE:-6.63
High:5.59
Open:5.44
Low:5.19
Close:5.33
Loading ...

Leerink Partners Sticks to Its Buy Rating for aTyr Pharma (ATYR)

TIPRANKS
·
26 Jun

aTyr Pharma to be added to Russell 2000, Russell 3000 Indices

TIPRANKS
·
26 Jun

aTyr Pharma Is Maintained at Overweight by Wells Fargo

Dow Jones
·
20 Jun

Analysts Offer Insights on Healthcare Companies: Cullinan Management (CGEM), aTyr Pharma (ATYR) and Pharvaris (PHVS)

TIPRANKS
·
09 Jun

aTyr Pharma Price Target Maintained With a $35.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Jun

aTyr Pharma announces interim analysis from Phase 2 EFZO-CONNECT

TIPRANKS
·
04 Jun

aTyr Pharma - 3 Out of 4 Efzofitimod-Treated Ssc-Ild Patients Show Improvement Based on Mrss Assesssment at 12 Weeks

THOMSON REUTERS
·
04 Jun

aTyr Pharma Inc - Efzofitimod Generally Safe and Well Tolerated at All Doses

THOMSON REUTERS
·
04 Jun

aTyr Pharma Announces Findings From Interim Analysis of Ongoing Phase 2 Efzo-Connect™ Study of Efzofitimod in Systemic Sclerosis-Related Interstitial Lung Disease (Ssc-Ild)

THOMSON REUTERS
·
04 Jun

aTyr Pharma presents three posters on efzofitimod at ATS 2025 Conference

TIPRANKS
·
19 May

aTyr Pharma Price Target Maintained With a $35.00/Share by HC Wainwright & Co.

Dow Jones
·
19 May

BRIEF-aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
17 May

ATyr Pharma Plans Investigational New Drug Filing for ATYR0101 in Pulmonary Fibrosis

MT Newswires Live
·
14 May

aTyr Pharma Advances aTyr0101 to Ind Candidate Stage for Pulmonary Fibrosis

THOMSON REUTERS
·
14 May

aTyr Pharma Q1 EPS $(0.17) Beats $(0.19) Estimate

Benzinga
·
08 May

aTyr Pharma Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Press Release: aTyr Pharma Announces First Quarter 2025 Results and Provides Corporate Update

Dow Jones
·
08 May

When Will aTyr Pharma, Inc. (NASDAQ:ATYR) Turn A Profit?

Simply Wall St.
·
30 Apr

aTyr Pharma Presents Preclinical Data for NRP2-Targeting Antibody ATYR2810 at the American Association for Cancer Research (AACR) Annual Meeting 2025

GlobeNewswire
·
29 Apr

US High Growth Tech Stocks to Watch in 2023

Simply Wall St.
·
09 Apr